Northern Technologies International Corporation (NTIC) Earnings Call Transcript & Summary

January 6, 2022

NASDAQ US Materials Chemicals earnings 36 min

Earnings Call Speaker Segments

G. Lynch

executive
#1

Good morning, everyone. Patrick Lynch here, and I serve as CEO of NTIC. Joining me is Matt Wolsfeld, who holds the CFO position at NTIC. I want to point out that we put out a press release this morning covering our financial results for the first quarter of fiscal 2022, and you can find it on ntic.com. To kick things off, I want to wish each of you a healthy and prosperous New Year in 2022. I also want to remind all of you about our Annual Meeting of Stockholders, which is coming up on January 21. There's one point I want you to remember: the meeting is going to be held in person, but because of the COVID-19 pandemic, we're really encouraging all stockholders to submit their votes in advance through a proxy. Protecting the health and safety of both our stockholders and our employees matters a great deal to us, and our view is that we can more effectively follow CDC and state safety rules if we hold attendance down to the smallest possible number and keep the meeting brief, doing nothing more than announcing the election results and skipping any business presentation in 2024. For the rest of today's session, we'll walk through several important elements of our Q1 fiscal 2022 financials, share a short business update, and wrap things up with a Q&A portion. All told, fiscal 2022 has kicked off with record sales, since we saw robust demand in the first quarter throughout numerous markets worldwide, which we find highly encouraging; we're also thrilled about the announcement we made in Q1 that we purchased the other 50% ownership stake in Harita-NTI, the ZERUST joint venture we have in India, which we call ZERUST India. Starting September 1, ZERUST India's financials became part of our consolidated statements, which means they're now reflected for the whole first quarter of fiscal 2022. So instead of being reported under joint venture operating income, ZERUST India's sales now show up in our income statement on a consolidated basis. There were also a number of one-time financial charges and accounting adjustments tied to this deal, and Matt will walk through those in more detail during his prepared remarks. Demand was strong in the first quarter, driving our total consolidated net sales up 42.4% versus the quarter that ended November 30, 2020, reaching a quarterly record of $18.2 million. Higher worldwide demand, the bounce-back from COVID-19, and the addition of ZERUST India all drove gains in every product category, which together account for most of the rise in consolidated sales compared with last year. During the first quarter of fiscal 2022, ZERUST India added — pardon me, $2.453 million to NTIC's consolidated net sales. Setting aside that extra business from ZERUST India, our organic growth was still robust. That said, NTIC has felt the sting of serious inflationary pressure, which has pushed up what we pay for raw materials and labor, along with heavy strain throughout our global supply chain and the ongoing effects of the COVID-19 pandemic. Regrettably, our bottom line fell short in Q1 because of a number of nonrecurring charges tied to the ZERUST India deal, along with increased costs for raw materials, freight, and labor. Although we intend to roll out specific steps to counter these inflationary pressures, we expect those steps to kick in during the back half of fiscal 2022. With that context set, let's dig into what drove the first quarter in greater depth; for Q1, which closed on November 30, 2021, consolidated net sales overall rose 42.4%, reaching a record quarterly figure of $18.2 million, compared with the first quarter that ended November 30, 2020. Looking at it by business unit, that figure included growth of 72.7% for Zerust Oil & Gas net sales, 47.3% for Natur-Tec net sales, and 38.9% for ZERUST Industrial net sales. Our joint ventures, whose results are not consolidated in our financial statements, posted total net sales of $26.8 million for the fiscal 2022 first quarter. That marks a 1% gain versus the equivalent period a year earlier and shows sustained strength in worldwide demand for our offerings, coming from both current and new customers. At our wholly-owned NTIC China subsidiary, fiscal 2022 first quarter net sales dropped 10.7% to $4.1 million versus the first quarter of fiscal 2021. In our view, the primary cause of that year-over-year decrease in NTIC China sales was lockdowns related to COVID-19 plus softer economic conditions in China. Even with near-term swings in that market, we still expect China will probably turn into our biggest geographic market over the next several years. To back this major opportunity, our new plant in Shanghai, China should be opening shortly, and it will support our R&D product — production, sales and marketing, and training activities across the region. Now shifting to our Zerust Oil & Gas product group. The ongoing headway we're achieving in this sizable and attractive market gives me confidence. Fiscal 2022 first quarter Zerust Oil & Gas sales climbed 72.7% versus the same period last fiscal year; we keep seeing stronger growth and market interest worldwide for our oil and gas solutions, which cover uses such as safeguarding aboveground oil storage tanks and pipeline casings against corrosion. We anticipate oil and gas will exceed fiscal 2021 sales through the rest of fiscal 2022. Now to our Natur-Tec bioplastics business. Natur-Tec sales came in at $3.8 million for the fiscal 2022 first quarter, up 47.3% versus the same period last fiscal year. That represents the strongest quarterly Natur-Tec sales level since the COVID-19 pandemic started 2 years ago. Even so, we foresee quarterly swings persisting in the near term as the COVID-19 pandemic carries on and major users of compostable plastics move in and out of lockdowns. Our — or run at reduced capacities. The long-term opportunities for us in the global compostable plastics market are thrilling. We remain focused on creating tailored solutions for particular customer product requirements that can't be found anywhere else. Also, our outlook on Natur-Tec staying strongly positioned in the sizable, attractive compostable plastics sector continues to be positive. To wrap up what I had prepared, the record sales increase we saw in the first quarter gives us encouragement, and we are working hard to boost our profitability. For the first quarter, our sales increase continued to be fueled by strategies focused on broadening both our product offerings and the geographic end markets we serve, and that's undergirded by a strong balance sheet, an experienced leadership team, and a business model that doesn't rely heavily on assets. Even though a lot of uncertainty remains around the globe, we believe NTIC is set up to deliver another year of healthy revenue growth and profitability in fiscal 2022. With that overview complete, I'll pass things along to Matt Wolsfeld, who will walk through our financial results for the first quarter of fiscal 2022.

Matt Wolsfeld

executive
#2

Appreciate that, Patrick. The quarter that closed on November 30, 2021 marks our first since wrapping up the purchase of the remaining 50% ownership stake in our Indian joint venture — the one we call ZERUST India — for $6.25 million. We covered that purchase price through a mix of cash we had on hand and draws on our revolving line of credit, which was also raised to $5 million as part of the transaction. Thanks to this acquisition, ZERUST India's financial results are now included in our consolidated financial statements starting September 1, the first day of our first quarter of fiscal 2022. On top of that, in the fiscal 2022 first quarter we recorded a gain on the acquisition of $3.95 million for the quarter, and that shows up in the line item remeasurement gain on acquisition of equity method investee on our consolidated statement of operations. Digging into our consolidated results a bit more, versus the prior fiscal year period, NTIC's consolidated net sales rose 42.4% in the fiscal 2022 first quarter, reaching a quarterly record, driven by the positive trends Patrick walked through in his prepared remarks along with the additional sales from ZERUST India. Although we expect those positive trends to carry on through fiscal 2022, we do anticipate some softness in sales in the near term, mainly because of the ongoing COVID-19 pandemic and its variants. Even with a 1% rise in first quarter sales across our global joint ventures, first quarter joint venture operating income fell 12.3% versus the prior fiscal year period; that drop is mainly due to the purchase of the remaining 50% of ZERUST India and weaker profitability at the company's joint ventures. Total first quarter fiscal 2022 operating expenses came to $7.1 million. The 19.9% increase over the prior fiscal year period stemmed primarily from the additional expense tied to the ZERUST India acquisition and higher selling expenses linked to greater consolidated sales, along with increased wages, travel expenses and R&D investments. Operating expenses as a percentage of net sales were 39%, versus 46.3% for the same period last fiscal year. As our first quarter results show, ZERUST India — the ZERUST India transaction lifted our net sales and operating expenses since it is now consolidated with our financial results, and it reduced our equity and income from joint ventures, in each case compared to the same period last fiscal year. And we expect that this acquisition will keep having these effects on our financial results for the rest of fiscal 2022. Cost of goods sold as a percentage of net sales climbed to 69% during the 3 months ended November 30, 2021, compared to 65% during the same period last fiscal year, mainly because of price increases in raw materials and higher labor costs. Even though, like Patrick mentioned, we plan to take some steps to tackle inflation, we anticipate those inflationary pressures will remain through at least the second quarter of fiscal 2022, and we don't anticipate seeing any payoff from those steps until the latter half of fiscal 2022. For the fiscal 2022 first quarter, NTIC posted net income of $4.7 million, or $0.48 per diluted share, versus $1.3 million, or $0.13 per share, in the fiscal 2021 first quarter. If you set aside the onetime gain of $3.9 million tied to buying the remaining 50% ownership stake in ZERUST India along with other related adjustments, NTIC's non-GAAP adjusted net income came to $780,000, or $0.08 per diluted share, for the fiscal 2022 first quarter, compared with $1.3 million, or $0.13 per diluted share, in the same quarter a year earlier. You can find a reconciliation of GAAP to non-GAAP financial measures in our first quarter earnings press release issued this morning. Working capital stood at $25.8 million as of November 30, 2021, which included $8 million in cash and cash equivalents and $5,000 in available-for-sale securities, versus $25.2 million as of August 31, 2021, which included $7.7 million in cash and cash equivalents and $5,000 in available-for-sale securities. As of November 30, 2021, the company held almost $22 million in investments in joint ventures, roughly 54% of which, or nearly $11.6 million, was in cash, with the rest mostly invested in other working capital. In the fiscal 2022 first quarter, NTIC's Board of Directors raised our regular quarterly cash dividend by 7.7% to $0.07 per share, which was paid on November 17, 2021, to shareholders of record on November 3, 2021. So wrapping up our prepared remarks, we're concentrating on making the adjustments our business needs to get through the near-term expense, raw material and supply chain challenges. Beyond that, we keep investing throughout our global operations to back our significant long-term growth opportunities. Though near-term uncertainty seems to have risen lately, particularly given the COVID variants, we think fiscal 2022 overall will be another solid year for NTIC when it comes to sales and profitability. With that overview, Patrick and I are glad to take any questions.

Tim Clarkson

analyst
#3

Strong quarter. I just need some clarity, since it seems to me that operational profits came in significantly higher, yet you're stating that under GAAP — the non-GAAP figures — profitability ended up lower. What I'm wondering is, which onetime expenses showed up, or have those been folded into the onetime gain? On what accounting basis did you handle that?

Matt Wolsfeld

executive
#4

Right, so the onetime expenses tied to the transaction sit within the — we separated those out in the non-GAAP calculation located at the back of the press release. So certain costs relate to the transaction. There's also fresh amortization expense recorded this quarter, meaning amortization of the new intangibles sitting on our balance sheet, plus a tax impact from the items we mentioned that get added back. So those things are captured in the — to arrive at the non-GAAP numbers, and they sit inside our normal operating expenses that you're seeing on our income statement.

Tim Clarkson

analyst
#5

All right. So, from an outsider's perspective, it appears you're clearly profitable, and this quarter had greater intrinsic profitability than the previous one, yet you've got all these figures fluctuating, mirroring GAAP and non-GAAP earnings.

Matt Wolsfeld

executive
#6

Yeah. It's — I mean, when you look at the income statement for the 3 months ended fiscal 2022 versus earlier years, reconciliation can be tough at times due to the transaction, since that deal happened during the quarter, and also since you're moving away from equity consolidation of ZERUST India toward full consolidation of ZERUST India. So basically, you're putting $500,000-plus of expenses onto the operating expense line tied to India. You're putting the sales and cost of goods sold onto the top line. Then, in the end, you're taking income away from the joint venture operating line compared to what would have been reported there before regarding the consolidation. So going quarter-to-quarter is somewhat challenging given the adjustments. But on the whole, the primary problem this quarter was that sales rose and sales were strong. Sales, when compared with the fourth quarter a year ago, the income from — the sales and income from our oil and gas were quite substantial in the fourth quarter. And so there's somewhat of a decline into the first quarter with the revenue we recognized. And clearly, there are varying gross margins tied to that. Past that, throughout the ZERUST Industrial market, the gross margins in our first quarter and what we're observing sort of in the second quarter is that as resin costs rose — those being the primary materials, the primary raw materials used in our product — things were quite volatile over the last 6 months of the prior fiscal year and across the first 3 months of this year. So we've reached a stage where we're making changes to address that and to boost our profitability. But it's going to take a bit of time for that to sort of move through our inventory and get passed along. So the expectations are that we'll be able to raise our gross margins throughout the — from sort of now or February onward, with higher gross margin through the industrial products. And also the expectations that we'll have greater sales in the second half of fiscal 2022 tied to oil and gas, comparable to what we achieved last year. And clearly, the gross margins in the oil and gas business are superior and stronger than those in the industrial business. So that ought to restore some profitability too. So I'd anticipate that in our first and second quarters there will be some, let's call it, gross margin pressures we're contending with because of supply chain problems, because of raw material problems and raw material pricing, but we'd anticipate much of that being resolved in the second half of the year. From a profitability perspective, we continue to expect a really robust year. And on the sales side, even after removing the $2.5 million in revenue that ZERUST India added over the first 3 months of the year, we still recorded meaningful gains in sales across every category. That's something we're quite enthusiastic about. To be specific, when you compare revenue from the fourth quarter against the first quarter, Natur-Tec sales rose by nearly 50%. And that's fourth quarter versus first quarter, not first quarter versus first quarter — my mistake, I said that wrong. Natur-Tec's total sales climbed 30% on a fourth quarter to first quarter basis and nearly 50% on a first quarter to first quarter basis. In a similar vein, while oil and gas sales declined from the fourth quarter to the first quarter, they rose 72% when comparing the first quarter to the first quarter. So we're fairly optimistic about the direction sales are moving. And also about the steps we've taken to address some of the profitability challenges. But we feel quite good about how we're positioned as we move through the remainder of the year.

Tim Clarkson

analyst
#7

Absolutely. Regarding the compostable segment, I observed while at Costco that they are beginning to transition toward compostable packaging. My impression is they're working with a different supplier. So how would you characterize what sets Natur-Tec's compostable offerings apart?

G. Lynch

executive
#8

The primary thing that has always distinguished us is this — we rely on, or purchase, the compostable resins sold in the marketplace that come from a few extremely large chemical manufacturers. However, on their own, those materials lack particular mechanical characteristics that allow for straightforward production and processing. Beyond that, when only those resin systems are used by themselves, the resulting goods are typically less strong. So we purchase those resin systems. We introduce our own chemistries into them. This makes processing simpler, which lowers expenses and simultaneously raises quality; the completed items also end up with superior mechanical strength. That is the way we set ourselves apart within the marketplace. On top of that, we avoid pursuing every commodity application. We consistently aim to locate specialty uses in which our technology genuinely sets us apart — distinguishes us from rivals, since we are able to make specific items that no one else is capable of producing.

Tim Clarkson

analyst
#9

Certainly, certainly. Alright, that works. Then just one more item, regarding oil and gas. I'm aware that you're achieving some headway by applying that technology to — particularly pipelines. Has anything moved forward more on that front? Or would you say it's simply something that continues?

G. Lynch

executive
#10

It continues. Nothing has come about lately from us that adds to it.

Scott Billeadeau

analyst
#11

Some of the things I was going to ask have already come up. But looking ahead, when you have something like that India transaction, where essentially all of it shifts above the line, did operating profits in India differ at all from what you see at a number of the other joint ventures? Or is it roughly consistent with the rest, depending on scale or whatever else you intend to do there?

Matt Wolsfeld

executive
#12

Generally speaking, I'd tell you that many of our JVs ran into comparable problems tied to resin pricing. Certain joint ventures have done a better job and managed to pass raw material costs along to their customers, while others haven't. When you look specifically at the — so that part is only from the JV perspective. Let me step back now and speak to what you raised about India. During the prior year, income contributed by ZERUST India in Q1 came to roughly $280,000; that represented our 50% share. In the current year, at 100% contribution, we recorded approximately $420,000. So if you look at it that way, ZERUST India was a bit less profitable during the first quarter of this year compared with the year before. Once again, that reflects some of the same challenges everyone else is facing.

Scott Billeadeau

analyst
#13

Thanks, and good morning. Turning to oil and gas, how much visibility do you actually have when it comes to pipeline volumes compared with tank bottom volumes? Are the two running at different levels right now? Could you share some perspective on that? I realize the pipeline business is relatively new, but can you split those out for us at all?

Matt Wolsfeld

executive
#14

Sure, what I meant was that when we look at how the second half of last year came back on the oil and gas side, the pipeline segment played a big part in that. Looking ahead across the rest of this fiscal year, and considering the projects we can already see coming in the next calendar year and over the next eight months or so of this fiscal year, I'd say the work we have lined up splits about evenly between tank bottom projects and pipeline projects, which is a good thing. Looking at what lies ahead for us, especially given the attention we've received since the API technical report was published and similar developments, there's a lot of enthusiasm on our end about what oil and gas could deliver, I'd say, across the coming 12 to 18 months.

Auguste Richard

analyst
#15

Matt, I want to make sure I've got this right — how much extra OpEx did India add during the first quarter? And should we expect that same level moving forward?

Matt Wolsfeld

executive
#16

Right. The added operating expenses that landed on our operating expense line came to roughly $520,000, I believe. And for at least the next 3 quarters, my expectation is that it stays fairly flat.

Auguste Richard

analyst
#17

Understood. Then the softness in China really stood out. Is that a difficult comparison? Is it the auto industry dealing with supply chain problems? Could you give us a bit more detail about the softness in that region?

G. Lynch

executive
#18

At this moment, that is indeed the standout situation in the Chinese market. My sense is they're experiencing continuing difficulties related to COVID along with other weakness in their market. So we anticipate that will prove short-lived as the pandemic recovery continues, but that is essentially what we're dealing with in China.

Auguste Richard

analyst
#19

All right. All right, that's clear to me. Then regarding Europe, I saw that your vehicle sales came in fairly soft, and I wanted to ask whether the joint ventures in that region, along with your business there, took a hit from that?

Matt Wolsfeld

executive
#20

I can address — pardon me.

G. Lynch

executive
#21

Don't worry about it, Matt. That's okay.

Matt Wolsfeld

executive
#22

No, what I meant to say is that I can address Excor, which is more or less the biggest one — when you consider the sales volume we have in Europe, it definitely makes up the largest part. What I'm able to tell you is that — and this will also appear in our Q — Excor Germany's sales went up in the first quarter versus the first quarter a year ago, by roughly 20%. Yet its contribution to overall income fell by roughly 9%. So once more, we're observing a few comparable problems in that we can see the opportunities that exist. We're pursuing many of those opportunities. Despite certain supply constraints, the question is simply how to handle the — both the rise in operating expenses that we're experiencing and the pressure on gross margin as well.

Auguste Richard

analyst
#23

Understood. Then moving to the final item: you have certain cost-cutting measures underway, and are those also included in the strategy to support gross margins by passing along to your customers the added expense you're absorbing?

Matt Wolsfeld

executive
#24

Correct; we are — at this very moment we're squarely engaged in what you could call a fuller examination of the options available to us regarding gross margin. That will encompass all the way from freight expenses to matters of internal labor to the amounts we're handing over for goods to possibly considering bringing some production in-house so that gross margin improves. Comparable actions we'll be in a position to take that give us greater command over our own product, particularly in light of certain unpredictabilities existing in the marketplace. Among the major items we've observed that have proven extremely unstable are shifts in lead time tied to our use of certain subcontractors. What you generally encounter is that it might not be the primary input for a product, but rather a minor input — or in situations where you've contracted out particular work, a minor part that proves hard to source or whose cost has gone up. Consequently, far greater stress from where we sit has been applied to the procurement cycle, on the buying side of that procurement process, to guarantee they possess whatever is required promptly and can subsequently convert it and get it to the customers; and so — and I'd note we have devoted far more hours across the last 6 months handling supply problems than anything we had previously needed to undertake. So yes, we are definitely quite conscious of the situation regarding gross margin and are tackling each and every facet of it that lies within our reach.

Auguste Richard

analyst
#25

Understood. That logic tracks well. So is it reasonable to think you'll need to hold somewhat more stock moving ahead, simply to avoid getting caught by these kinds of interruptions?

Matt Wolsfeld

executive
#26

Yes, in some spots. What I mean is, for some items, that's true. Yet much like what you observe when you check out a car lot, at this moment we're producing as fast as we're able; and since sales sit where they do, we're restocking as quickly as possible. So for particular items we're attempting to pull in inventory, except it's leaving through the door as rapidly as it arrives.

Jim Dowling

analyst
#27

Yes. I've got two questions about Natur-Tec. That sales growth you mentioned — does any portion of it come from customers you brought on over the past 3 to 6 months? Then my second one: could you describe, from a geographic standpoint, where Natur-Tec's sales are strongest?

G. Lynch

executive
#28

Let's see — well, sure, we bring on new customers all the time. I can't claim we landed anything dramatically — any dramatic new accounts, though — what's behind our higher sales is clearly, you know, some customers coming back who had fallen away while COVID was going on, plus a few new applications too. As for where we sell geographically at present, North America and Southeast Asia make up our main markets, especially India, Pakistan, Sri Lanka and Bangladesh, and we're doing somewhat more in China, though things there are moving a bit slower at the moment owing to their regulatory drive, especially when it comes to compostables — it's not — it hasn't moved as quickly as we'd initially anticipated. On top of that, we're picking up customers in Europe now too. So, you know, we're spreading out across different regions and expanding on that front.

Jim Dowling

analyst
#29

How do North American revenues split versus the rest of the world?

G. Lynch

executive
#30

Matt, have you got that on hand?

Matt Wolsfeld

executive
#31

Yeah. In the first quarter of 2022, the one we just wrapped up, Natur-Tec North America sales came to roughly $1.4 million. Natur-Tec India sales were just above $2 million. And China sales totaled around $300,000-plus; so when you add it up — total Natur-Tec revenue came in under $3.8 million.

Scott Billeadeau

analyst
#32

I was curious — when you're pursuing either reducing costs or finding suppliers, what does that look like within each of the JVs? Must it be handled individually for every joint venture? Or is there a situation where, hey, certain chemicals are shared — ones you purchase for the entire group? Could you give us some insight into what sort of procedure that involves as you move through each JV one at a time?

G. Lynch

executive
#33

For the most part, this happens individually per JV, since most of our raw materials are ideally obtained locally and produced nearby as well. What I mean is, packaging represents our core operation, and transporting empty packaging across the globe doesn't really add up; that's the reason we aim to produce as near as possible to the customer, the end user.

Scott Billeadeau

analyst
#34

Understood. So I'm guessing you can pass along certain best practices, but ultimately this is largely a call made at the local level?

G. Lynch

executive
#35

That's right.

G. Lynch

executive
#36

I simply want to express my appreciation to all of you for joining us today and for your interest in NTIC. Have a wonderful day, and I look forward to our next meeting in the coming quarter.

Operator

operator
#37

This concludes today's conference call. Thank you for participating. You may now disconnect.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Northern Technologies International Corporation transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Northern Technologies International Corporation earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Northern Technologies International Corporation or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.